News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
55,258 Results
Type
Article (2433)
Company Profile (31)
Press Release (52794)
Multimedia
Podcasts (2)
Webinars (2)
Section
Business (18022)
Career Advice (103)
Deals (3142)
Drug Delivery (1)
Drug Development (5405)
Employer Resources (13)
FDA (1540)
Job Trends (1877)
News (28062)
Policy (1831)
Tag
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (1)
2024 Biotech Bay Standard (5)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (291)
Allergies (2)
Alliances (4825)
ALS (3)
Alzheimer's disease (123)
Antibody-drug conjugate (ADC) (4)
Approvals (1561)
Artificial intelligence (25)
Autoimmune disease (1)
Automation (5)
Bankruptcy (17)
Best Places to Work (1795)
BIOSECURE Act (1)
Biosimilars (11)
Biotechnology (20)
Bladder cancer (14)
Brain cancer (4)
Breast cancer (16)
Cancer (204)
Cardiovascular disease (13)
Career advice (93)
Career pathing (3)
CAR-T (9)
Cell therapy (43)
Cervical cancer (5)
Clinical research (4686)
Collaboration (121)
Compensation (21)
COVID-19 (69)
CRISPR (6)
C-suite (67)
Cystic fibrosis (5)
Data (223)
Denatured (1)
Depression (5)
Diabetes (33)
Diagnostics (815)
Digital health (2)
Diversity, equity & inclusion (3)
Drug discovery (11)
Duchenne muscular dystrophy (14)
Earnings (4025)
Editorial (2)
Employer branding (1)
Employer resources (13)
Events (7287)
Executive appointments (194)
FDA (1717)
Featured Employer (18)
Frontotemporal dementia (1)
Funding (161)
Gene editing (14)
Generative AI (2)
Gene therapy (51)
GLP-1 (30)
Government (283)
Guidances (4)
Healthcare (2287)
Huntington's disease (2)
IgA nephropathy (3)
Immunology and inflammation (6)
Indications (1)
Infectious disease (76)
Inflammatory bowel disease (8)
Influenza (1)
Intellectual property (5)
Interviews (21)
IPO (1144)
Job creations (192)
Job search strategy (74)
Labor market (1)
Layoffs (16)
Leadership (1)
Legal (224)
Liver cancer (7)
Lung cancer (35)
Lymphoma (15)
Management (6)
Manufacturing (25)
MASH (3)
Medical device (1748)
Medtech (1749)
Mergers & acquisitions (2096)
Metabolic disorders (51)
Multiple sclerosis (15)
Neurodegenerative disease (5)
Neuroscience (166)
NextGen: Class of 2025 (818)
Non-profit (799)
Northern California (276)
Obesity (17)
Opinion (10)
Ovarian cancer (6)
Pain (5)
Pancreatic cancer (4)
Parkinson's disease (7)
Partnered (2)
Patents (9)
Patient recruitment (11)
Peanut (1)
People (8207)
Pharmaceutical (11)
Phase I (1235)
Phase II (1852)
Phase III (1978)
Pipeline (120)
Policy (4)
Postmarket research (239)
Preclinical (400)
Press Release (7)
Prostate cancer (10)
Psychedelics (1)
Radiopharmaceuticals (25)
Rare diseases (34)
Real estate (434)
Recruiting (6)
Regulatory (1529)
Reports (1)
Research institute (316)
Resumes & cover letters (12)
Schizophrenia (3)
Series A (37)
Series B (27)
Service/supplier (1)
Sickle cell disease (7)
Southern California (189)
Spinal muscular atrophy (2)
Sponsored (2)
Startups (531)
Supply chain (9)
The Weekly (1)
United States (2497)
Vaccines (22)
Venture capitalists (3)
Weight loss (5)
Women's health (3)
Worklife (1)
Date
Today (16)
Last 7 days (70)
Last 30 days (296)
Last 365 days (3670)
2025 (1146)
2024 (3845)
2023 (4501)
2022 (5990)
2021 (5701)
2020 (5143)
2019 (5351)
2018 (3823)
2017 (2689)
2016 (2567)
2015 (2535)
2014 (1827)
2013 (1355)
2012 (1287)
2011 (1324)
2010 (1142)
Location
Africa (51)
Alabama (7)
Alaska (3)
Arizona (25)
Arkansas (4)
Asia (3726)
Australia (504)
California (592)
Canada (161)
China (53)
Colorado (21)
Connecticut (12)
Delaware (22)
Europe (7618)
Florida (89)
Georgia (54)
Idaho (10)
Illinois (62)
India (4)
Indiana (47)
Iowa (3)
Japan (24)
Kansas (8)
Kentucky (1)
Louisiana (1)
Maine (1)
Maryland (79)
Massachusetts (425)
Michigan (40)
Minnesota (22)
Mississippi (1)
Missouri (9)
Montana (3)
Nebraska (3)
Nevada (13)
New Hampshire (7)
New Jersey (198)
New Mexico (3)
New York (199)
North Carolina (132)
North Dakota (2)
Northern California (276)
Ohio (25)
Oklahoma (4)
Oregon (8)
Pennsylvania (148)
Rhode Island (5)
South America (63)
South Carolina (4)
Southern California (189)
Tennessee (41)
Texas (84)
Utah (29)
Virginia (23)
Washington D.C. (7)
Washington State (136)
West Virginia (2)
Wisconsin (6)
55,258 Results for "pixium vision".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pixium Vision announces the conversion of the safeguard proceedings into receivership
Pixium Vision SA announces the conversion of the safeguard proceedings which has been in place since October 9, 2023 into receivership.
November 13, 2023
·
2 min read
Deals
Pixium Vision announces the launch of a process to find buyers
Pixium Vision SA announces that a tender process for the purpose of finding buyers to acquire the Company’s business will be published tomorrow.
October 18, 2023
·
3 min read
Pixium Vision announces the 48-Month Trial Results in Severe Atrophic AMD
Pixium Vision SA announces data from a first in human trial to assess the efficacy and safety of the PRIMA photovoltaic retinal stimulation microchip for improving visual acuity 48 months post implantation in patients with severe central vision impairment due to dry age-related macular degeneration
November 14, 2023
·
5 min read
Pixium Vision announces its financial results for H1 2023 and provides update
Pixium Vision SA, a bioelectronics company developing innovative vision systems to enable patients who have lost their sight to live more independent lives, announces its financial results for the first half of 2023.
October 26, 2023
·
8 min read
Pixium Vision convenes its Annual Meeting of Shareholders on June 13, 2023
Pixium Vision SA announces that it will hold its annual meeting of shareholders at 14:00 CET on June 13, 2023 at Pixium Vision’s headquarter office.
May 10, 2023
·
1 min read
Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminated ESGO financing facility
Pixium Vision announces the agreement to extend the maturity date of the outstanding notes associated with the terminatedESGO financing facility
July 11, 2023
·
3 min read
Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit
Pixium Vision announces receipt of € 1.8 million from the French Government as Research Tax Credit
June 8, 2023
·
4 min read
Biotech Bay
Science Corporation Acquires Pixium’s PRIMA Retinal Implant, Extending and Diversifying Its Commitment to Vision Restoration Through Brain-Computer Interface Technology
Science Corporation has acquired the IP and related assets for the PRIMA retinal implant.
April 25, 2024
·
3 min read
Pixium Vision announces the implementation of a bridge financing with Bpifrance and Sofinnova and a reverse stock split on the basis of 1 new share for 50 existing shares
Pixium Vision SA announces that it successfully negotiated a 3 million Euro convertible shareholders’ loan with Bpifrance and Sofinnova.
July 28, 2023
·
8 min read
Business
Pixium Vision announces the availability of its annual report for the financial year 2022
Pixium Vision SA announces that its annual report for the year 2022 has been made available on the Company’s website.
April 25, 2023
·
1 min read
1 of 5,526
Next
